Home
Drug Discovery & Development

Drug Discovery & Development

Phage Proteins Help Improve Drug Delivery

Shelby Bradford, PhD | Jan 13, 2025 | 1 min read

Researchers used bacteriophages’ ability to target specific bacteria to develop nanoparticle vehicles for antibiotics.

Abstract blue nautilus shell displaying a characteristic fractal shape

Attacking Cancer Targets with Radiotherapeutics

The Scientist Staff | Jan 8, 2025 | 4 min read

John Babich from Ratio Therapeutics explains how radiopharmaceuticals can be designed to better treat cancer, alone and in combination with immunotherapies.

Bio-Rad Extends Range of Foresight Pro Prepacked Chromatography Columns for Biotherapeutic Production

Bio-Rad Laboratories | Jan 7, 2025 | 2 min read

Foresight Pro 45 cm ID Column Provides a Convenient and Reliable Solution for Purification of Biomolecules in Downstream Bioprocessing.

Advances in Cancer Therapies and Diagnostics

The Scientist Staff | Jan 6, 2025 | 2 min read

Learn about the latest research in cancer biology and translational applications.

An illustration of an orange tau fibril in front of a blue background.

Uncovering the Unexpected: Developing a Novel Anti-Tau Therapy

Charlene Lancaster, PhD | Dec 31, 2024 | 4 min read

Ke Hou generated a compound that prevents tau aggregation in the murine brain, but the potential Alzheimer’s disease therapy also had a surprising property.

Gram-negative, rod-shaped bacteria expressing pili.

Building Bacterial Drug Factories

Aparna Nathan, PhD | Dec 30, 2024 | 3 min read

Drug-manufacturing bacteria can provide a more targeted approach to treat gut diseases.

A man holds his knee and grimaces in pain while sitting in front of a bridge.

A Nanoparticle Approach to Treat Torn Tendons

Aparna Nathan, PhD | Dec 29, 2024 | 4 min read

Alayna Loiselle has found a way to bring therapeutics straight to an injured tendon.

Graphic depicting a tumor being targeted by a drug

Great Anticancer Potential Comes in a Small Package

Niki Spahich, PhD | Dec 28, 2024 | 4 min read

Jingjing Sun developed a novel, ultra-small nanocarrier that actively targets tumor cells.

A conceptual illustration of scientists evaluating potential kinase inhibitors.

Leveraging Recombinant Kinases for Drug Discovery Research

The Scientist and Sino Biological | Dec 26, 2024 | 3 min read

As kinase dysfunction underlies many pathological conditions, scientists require high-quality active kinases for their therapeutic development programs.

3D conceptual image of antibodies on a blue background.

Improving the Efficiency and Reliability of Fully Human Antibody Drug Development

The Scientist Staff | Dec 16, 2024 | 2 min read

Microfluidic technology enables high-throughput, droplet-based antibody discovery in fully human antibody mice.

Brightfield microscopy image of Aspergillus fumigatus.

The Silent Pandemic of Antifungal Resistance

Danielle Gerhard, PhD | Dec 16, 2024 | 2 min read

As the world grapples with antimicrobial-resistant bacteria, another insidious threat looms large: drug-resistant fungi.

New Frontiers in Vaccine Development

The Scientist Staff | Dec 12, 2024 | 2 min read

Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.

Evotec SE announces first projects for LAB eN² drug discovery accelerator with Novo Nordisk

Evotec | Dec 11, 2024 | 3 min read

Novo Nordisk and Evotec select three projects from Boston University, Harvard University in collaboration with Mass General Brigham, and Joslin Diabetes Center to be developed within LAB eN² focusing on cardiometabolic diseases